Nuvectis Pharma has dropped plans to develop NXP800 in ovarian cancer after tallying two unconfirmed partial...
July 2025
Esta adquisición permite a ESTEVE ampliar su oferta de servicios de desarrollo y fabricación por...
Durch diese Übernahme kann ESTEVE seine Dienstleistungen im Bereich der Auftragsentwicklung und -fertigung für kleinmolekulare...
Cette acquisition permet à ESTEVE d’étendre ses services de développement et de fabrication sous contrat...
This acquisition enables ESTEVE to expand its contract development and manufacturing services for small-molecule active...
Frazier Life Sciences has gathered an impressive $1.3 billion in capital commitments for its 12th...
AbbVie has reportedly added Gilgamesh Pharmaceuticals to its shopping list. The Big Pharma teamed up...
Cancer cells undergo physically constraining processes, such as intravasation, extravasation, and tissue infiltration, that lead...
STOCKHOLM, July 31, 2025 /PRNewswire/ — BioArctic AB’s (publ) (NASDAQ Stockholm: BIOA B) partner Eisai...
STOCKHOLM, July 31, 2025 /PRNewswire/ — BioArctic AB’s (publ) (NASDAQ Stockholm: BIOA B) partner Eisai...